These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27430248)

  • 1. Inhibition of multiple myeloma cell proliferation by ginsenoside Rg3 via reduction in the secretion of IGF-1.
    Li Y; Yang T; Li J; Hao HL; Wang SY; Yang J; Luo JM
    Mol Med Rep; 2016 Sep; 14(3):2222-30. PubMed ID: 27430248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of 20 (S)-ginsenoside Rg3 on the proliferation inhibition and secretion of vascular endothelial growth factor of multiple myeloma cell line U266].
    Song Y; Hou J; Kang L; Gao S
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jun; 35(6):519-23. PubMed ID: 24985176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginsenoside Rg3 Suppresses Proliferation and Induces Apoptosis in Human Osteosarcoma.
    Li Y; Lu J; Bai F; Xiao Y; Guo Y; Dong Z
    Biomed Res Int; 2018; 2018():4306579. PubMed ID: 29750154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rg3 induces apoptosis in human multiple myeloma cells via the activation of Bcl-2-associated X protein.
    Luo Y; Zhang P; Zeng HQ; Lou SF; Wang DX
    Mol Med Rep; 2015 Sep; 12(3):3557-3562. PubMed ID: 25998024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of c-Met enhances sensitivity to bortezomib in human multiple myeloma U266 cells via inhibiting Akt/mTOR activity.
    Que W; Chen J; Chuang M; Jiang D
    APMIS; 2012 Mar; 120(3):195-203. PubMed ID: 22339676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silybin suppresses cell proliferation and induces apoptosis of multiple myeloma cells via the PI3K/Akt/mTOR signaling pathway.
    Feng N; Luo J; Guo X
    Mol Med Rep; 2016 Apr; 13(4):3243-8. PubMed ID: 26936429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway.
    Cao Y; Ye Q; Zhuang M; Xie S; Zhong R; Cui J; Zhou J; Zhu Y; Zhang T; Cao L
    PLoS One; 2017; 12(11):e0186520. PubMed ID: 29140979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EEN regulates the proliferation and survival of multiple myeloma cells by potentiating IGF-1 secretion.
    Huang EW; Xue SJ; Li XY; Xu SW; Cheng JD; Zheng JX; Shi H; Lv GL; Li ZG; Li Y; Liu CH; Chen XH; Liu H; Li J; Liu C
    Biochem Biophys Res Commun; 2014 May; 447(2):271-7. PubMed ID: 24704450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of DEPTOR induces apoptosis, increases chemosensitivity to doxorubicin and suppresses autophagy in RPMI-8226 human multiple myeloma cells in vitro.
    Zhang H; Chen J; Zeng Z; Que W; Zhou L
    Int J Mol Med; 2013 May; 31(5):1127-34. PubMed ID: 23503641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma.
    Pene F; Claessens YE; Muller O; Viguié F; Mayeux P; Dreyfus F; Lacombe C; Bouscary D
    Oncogene; 2002 Sep; 21(43):6587-97. PubMed ID: 12242656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
    Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2,4-Dihydroxy-3'-methoxy-4'-ethoxychalcone suppresses cell proliferation and induces apoptosis of multiple myeloma
    Zhu F; Jiang D; Zhang M; Zhao B
    Pharm Biol; 2019 Dec; 57(1):641-648. PubMed ID: 31564190
    [No Abstract]   [Full Text] [Related]  

  • 13. Ginsenoside Rh2 impedes proliferation and migration and induces apoptosis by regulating NF-κB, MAPK, and PI3K/Akt/mTOR signaling pathways in osteosarcoma cells.
    Li C; Gao H; Feng X; Bi C; Zhang J; Yin J
    J Biochem Mol Toxicol; 2020 Dec; 34(12):e22597. PubMed ID: 32762018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell.
    Xie Q; Wen H; Zhang Q; Zhou W; Lin X; Xie D; Liu Y
    Biomed Pharmacother; 2017 Jan; 85():16-21. PubMed ID: 27930981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 20-(s)-ginsenoside Rg3 induces apoptotic cell death in human leukemic U937 and HL-60 cells through PI3K/Akt pathways.
    Qiu XM; Bai X; Jiang HF; He P; Wang JH
    Anticancer Drugs; 2014 Oct; 25(9):1072-80. PubMed ID: 25035959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer.
    Yuan Z; Jiang H; Zhu X; Liu X; Li J
    Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXC195 induces apoptosis and endoplastic reticulum stress in human hepatocellular carcinoma cells by inhibiting the PI3K/Akt/mTOR signaling pathway.
    Chen XL; Fu JP; Shi J; Wan P; Cao H; Tang ZM
    Mol Med Rep; 2015 Dec; 12(6):8229-36. PubMed ID: 26496900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatment with ginsenoside Rg3 induces Akt-dependent senescence in human glioma cells.
    Sin S; Kim SY; Kim SS
    Int J Oncol; 2012 Nov; 41(5):1669-74. PubMed ID: 22922739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway.
    Jiang J; Yuan Z; Sun Y; Bu Y; Li W; Fei Z
    Biomed Pharmacother; 2017 Dec; 96():619-625. PubMed ID: 29035827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
    Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
    J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.